Pure Global

GENEWISE Fully-Automated Nucleic Acid Amplification Testing System - Indonesia BPOM Medical Device Registration

GENEWISE Fully-Automated Nucleic Acid Amplification Testing System is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20304420035. The device is manufactured by GENEWISE BIO CO., LTD from China, and is classified as Risk Class Kelas Resiko : C. The authorized representative in Indonesia is FOR ANY MEDICAL INDONESIA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : C
GENEWISE Fully-Automated Nucleic Acid Amplification Testing System
Analysis ID: AKL 20304420035

Risk Classification

Kelas Resiko : C

Product Class

Kelas : 2

Country of Origin

China

Authorized Representative

FOR ANY MEDICAL INDONESIA

AR Address

Jalan RS Fatmawati (Fatmawati Grand Centre) Blok II Kavling Nomor 215 RT.003 RW.010

Registration Date

Apr 29, 2024

Expiry Date

Dec 06, 2028

Product Type

Immunology Laboratory Equipment and Reagents

RNA Preanalytical Systems.

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing